NL
DE
Queen Máxima paid a virtual working visit to MITeC at Radboudumc on January 28th 2021. In November 2015, she opened the three innovative operation rooms of MITeC. Queen Máxima wanted to come back to hear and see what was done and accomplished the last years.
Prof. Maroeska Rovers PhD, Prof. Jurgen Fütterer PhD and Frank Nijsen PhD updated her on 28 January about the last five years. What were the goals in 2015 and are these goals still applicable for the coming years? Frank Nijsen PhD explained the Holmium project in which patients with untreatable liver tumors are treated with radio embolization. Queen Máxima and Frank talked about one of the first patients within the MITeC project, who lived longer and had a better quality of life as a result of the treatment.
You can watch the full working visit of queen Máxima here (Dutch only).
Related news items
Liver tumors irradiated from inside can be followed live from outside
17 February 2022 A Dutch research team from Radboud University Medical Center has visualized the injection of radioactive microspheres during treatment of a patient with liver tumors ‘live on screen’. read more
LUMO Labs and Oost NL invest in Aiosyn Investment accelerates development of artificial intelligence platform to improve diagnostics
7 February 2022 Aiosyn, a spin-off from Radboudumc, has received an investment from LUMO Labs. Oost NL is a co-investor. read more
Large AI project receives over €95 million for ten years of public-private research
23 September 2021 The Dutch Research Council (NWO) is to fund two consortia for a period of ten years. Radboudumc participates in the ROBUST consortium, which consists of 17 AI labs, eight of which are dedicated to healthcare. Radboudumc leads five of these eight labs. read moreNew start-up Patholyt will bring AI research into pathology diagnostics
21 September 2021 Patholyt is on a mission to accelerate the adoption of artificial intelligence in pathology diagnostics and improve the chances of cancer patients worldwide. Patholyt is a spin-off from Radboudumc, a frontrunner in computational pathology research. read more